ARGIRELINE (ACETYL HEXAPEPTIDE-3)

Skin, Hair & CosmeticCosmetic

Despite widespread use in cosmetic products, there's virtually no published research documenting its effectiveness. The theoretical mechanism is sound, but evidence remains anecdotal.

Primarily studied by cosmetic chemists and dermatological researchers investigating non-invasive alternatives to injectable anti-wrinkle treatments.

FDA Status
Research Only

Since Feb 2026

Evidence
Limited data
Studies

0 total

What is ARGIRELINE (ACETYL HEXAPEPTIDE-3)?

This synthetic six-amino-acid peptide was designed to interfere with nerve signals that cause facial muscles to contract. Cosmetic companies have incorporated it into anti-aging creams and serums as a topical alternative to botulinum toxin injections. Research focuses primarily on its potential to reduce expression lines through a different delivery method than traditional neurotoxin treatments.

The peptide works by disrupting the cellular machinery that nerve cells use to communicate with muscles. It interferes with a protein complex called SNARE, which normally helps nerve cells release chemical signals that tell muscles to contract. When applied topically, this disruption theoretically reduces the intensity of facial muscle movements that create wrinkles over time.

Reported Benefits

Wrinkle reduction
Expression line softening
Non-invasive Botox alternative
Skin smoothing

Regulatory Status

Research OnlyEffective: Feb 2026

Last verified: Feb 2026

Related Peptides

This information is for research purposes only and does not constitute medical advice. Always consult a licensed physician before using any peptides.